Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations

Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations

Wang Yang, Naifei Chen, Lingyu Li, Xiao Chen, Xiangliang Liu, Yongfei Zhang, Jiuwei Cui The Cancer Center of the First Hospital of Jilin University, Changchun, Jilin 130021, People’s Republic of ChinaCorrespondence: Jiuwei Cui Tel +86 431-8878-2178Fax +86-0431-88786134Email cuijw@jlu.edu.c...

Full description

Bibliographic Details
Main Authors: Yang W, Chen N, Li L, Chen X, Liu X, Zhang Y, Cui J
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Lung Cancer : Targets and Therapy
Subjects:
epidermal growth factor receptor (egfr) mutation
tumor mutation burden (tmb)
immune checkpoint inhibitor (ici)
lung adenocarcinoma (luad).
Online Access:https://www.dovepress.com/favorable-immune-microenvironment-in-patients-with-egfr-and-mapk-co-mu-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/favorable-immune-microenvironment-in-patients-with-egfr-and-mapk-co-mu-peer-reviewed-article-LCTT

Similar Items